Expect to see the pace accelerate at the Eli Lilly and Co. project on Lebanon’s north side as weather warms. The $9 million ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks ...

Expect to see the pace accelerate at the Eli Lilly and Co. project on Lebanon’s north side as weather warms. The $9 million pharmaceutical complex is about 7% complete, Jeff Wagner, community ...

While the recent launches of GLP-1 drugs from Novo Nordisk and Eli Lilly have been nothing short ... active pharmaceutical ingredients plant in Lebanon, Indiana, to plans for a $4.5 billion ...

Nearly 200 Eli Lilly and Co. employees from the Lebanon site under construction volunteered to distribute 75,000 diapers to ...

Eli Lilly and Co., which in 2022 was the first ... Facebook parent Meta Platforms Inc. struck a tentative deal with the city of Lebanon for an initial $800 million investment in a data center ...

Lilly to invest another $4.5B in Lebanon site for new ‘medicine foundry’ Eli Lilly and Co. said in October it will invest an additional $4.5 billion at its manufacturing site at the LEAP ...

Two newly published water studies from the state predict that supply will continue to outpace demand for the vital resource ...

Also in today’s newsletter, a record number of US companies weigh China exit, and Trump calls on Opec to push down global oil prices ...

The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...